Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Auteurs

Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F

  • Date de publication

    January 2025

  • Type

    Other

  • Review

    BMC Cancer

  • Researcher's name

    PICCART MARTINE

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    39789513

  • DOI

    10.1186/s12885-025-13460-1